Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Aminocyclopentyl fused heterotricylicamide modulators of chemokine receptor activity

Aminocyclopentyl fused heterotricylicamide modulators of chemokine receptor activity

US Patent 7557120 · Granted Jul 7, 2009

Estimated economic value: $88,433,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Photonic structure and method for manufacturing the same2025
Oxazolidinone compounds and methods of use thereof as antibacterial agents2025
Imidazo[2,1-f][1,2,4]triazin-4-amine derivatives as TLR7 agonist2025
Substituted piperazine amide compounds as indoleamine 2,3-dioxygenase (IDO) inhi2025
Arylalkyl pyrazole compounds as indoleamine 2,3-dioxygenase inhibitors2024
Substituted pyrazole compounds as indoleamine 2,3-dioxygenase inhibitors2024
Derivatives of resiquimod2024
Substituted tricyclic compounds as indoleamine 2,3-dioxygenase inhibitors2024
Substituted tetrahydroquinoline compounds as indoleamine 2,3-dioxygenase inhibit2024
Pyrimidine compounds useful as tyrosine kinase inhibitors2023
Combination of a PD-1 antagonist and a RAF inhibitor for treating cancer2022
[1.1.1] bicyclo compounds as indoleamine 2,3-dioxygenase inhibitors2022